You are here: All Products  > Antengene Acquires Global Rights to AstraZeneca Cancer Candidate

Antengene Acquires Global Rights to AstraZeneca Cancer Candidate

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products